|
Reactivity/
Applications |
Human/WB ELISA |
|
Size/Price |
50ug/1000 100ug/1800 |
|
Gene_Name/
Protein_Name |
TNFRSF17/Tumor necrosis factor receptor superfamily member 17 |
|
Human_gene_id/
Human_swiss_prot_no |
608/Q02223 |
|
Mouse_gene_id/
Mouse_swiss_prot_no |
/O88472 |
|
Immunogen |
Synthesized peptide derived from the Internal region of human CD269. |
|
Specificity |
CD269 Polyclonal Antibody detects endogenous levels of CD269 protein. |
|
Formulation |
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
|
|
Dilution |
Western Blot: 1/500 - 1/2000. ELISA: 1/10000. Not yet tested in other applications. |
|
Purification |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
|
|
Storage_stability |
-20°C/1 year |
|
Other_name |
TNFRSF17; BCM; BCMA; Tumor necrosis factor receptor superfamily member 17; B-cell maturation protein; CD269 |
|
Predicted_band(Da)/
Observed_band(KD) |
20138/20 |
|
|
| Content |
|
Western blot analysis of L929 293T MCF7 HELA using CD269 antibody. Antibody was diluted at 1:2000. Secondary antibody（catalog#：RS0002) was diluted at 1:20000 |
|
|
Western blot analysis of K562/JK using CD269 antibody. Antibody was diluted at 1:2000. Secondary antibody（catalog#：RS0002) was diluted at 1:20000 |
|
| |
